|
BBS7 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.225700E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.580500E-03 |
| Normal-vs-Stage2 |
1.603830E-01 |
| Normal-vs-Stage3 |
3.142400E-02 |
| Normal-vs-Stage4 |
1.716990E-01 |
| Stage1-vs-Stage2 |
6.432600E-01 |
| Stage1-vs-Stage3 |
9.827200E-01 |
| Stage1-vs-Stage4 |
8.758600E-01 |
| Stage2-vs-Stage3 |
6.005800E-01 |
| Stage2-vs-Stage4 |
5.861600E-01 |
| Stage3-vs-Stage4 |
8.731800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.243000E-03 |
| Normal-vs-AfricanAmerican |
7.296700E-03 |
| Normal-vs-Asian |
6.118400E-02 |
| Caucasian-vs-AfricanAmerican |
9.011200E-01 |
| Caucasian-vs-Asian |
8.595600E-01 |
| AfricanAmerican-vs-Asian |
8.587200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.76389999999782E-05 |
| Normal-vs-Female |
8.003400E-01 |
| Male-vs-Female |
8.411100E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.040000E-01 |
| Normal-vs-Extreme_Weight |
3.86060000000521E-05 |
| Normal-vs-Obese |
1.803700E-02 |
| Normal-vs-Extreme_Obese |
9.786000E-02 |
| Normal_Weight-vs-Extreme_Weight |
2.535800E-01 |
| Normal_Weight-vs-Obese |
7.593000E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.711800E-01 |
| Extreme_Weight-vs-Obese |
1.461630E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.134200E-01 |
| Obese-vs-Extreme_Obese |
7.030800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.401800E-01 |
| Normal-vs-Age(41-60Yrs) |
1.138370E-02 |
| Normal-vs-Age(61-80Yrs) |
1.256490E-03 |
| Normal-vs-Age(81-100Yrs) |
7.427700E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.488000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.477200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.583500E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.157600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.700430E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.126800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.202110E-04 |
| Normal-VS-Type2 PRCC |
3.163500E-02 |
| Normal-VS-KIRP CIMP |
9.219600E-01 |
| Normal-VS-Unclassified PRCC |
6.455600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
9.160000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.352390E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.734300E-02 |
| Type2 PRCC-VS-KIRP CIMP |
4.171800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.685630E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
8.868800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.350590E-04 |
| Normal-vs-N1 |
1.616050E-01 |
| Normal-vs-N2 |
2.853900E-02 |
| N0-vs-N1 |
2.551000E-01 |
| N0-vs-N2 |
8.707400E-01 |
| N1-vs-N2 |
5.638000E-01 |
|
|
